Fibroblast growth factor 23 is a predictor of aortic artery calcification in maintenance hemodialysis patients

Renal Failure

Volumn 35, Issue 5, 2013, Pages 660-666

  Chen, Zijin ^a   Chen, Xiaonong ^a   Xie, Jingyuan ^a   Ma, Xiaobo ^a   Zhong, Fang ^a   Hou, Liang ^a   Ling, Huawei ^a   Li, Xiao ^a   Ren, Hong ^a   Chen, Nan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; FGF23; Hemodialysis; Lateral lumbar radiography; Vascular calcification

Indexed keywords

CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; PREALBUMIN; UREA;

ABDOMINAL AORTA; ADULT; AORTIC ARTERY CALCIFICATION; ARTERY CALCIFICATION; ARTICLE; CALCIFICATION; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAINTENANCE HEMODIALYSIS; MAJOR CLINICAL STUDY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AORTIC DISEASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; END STAGE LIVER DISEASE; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84877856337     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.781844     Document Type: Article

References (30)

1. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(Suppl.113): S1-S130
2. Kauppila LI, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study. Atherosclerosis. 1997;132(2):245-250 (Pubitemid 27311017)
3. Honkanen E, et al. Abdominal aortic calcification in dialysis patients: Results of the CORD study. Nephrol Dial Transplant. 2008;23(12):4009-4015
4. Toussaint ND, et al. Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients. Nephrology (Carlton). 2011;16(4):389-395
5. Bellasi A, et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006;70(9):1623-1628 (Pubitemid 44606998)
6. Russo D, et al. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44(6): 1024-1030 (Pubitemid 39556482)
7. El-Saed A, et al. The prevalence of aortic calcification in Japanese compared to white and Japanese-American middleaged men is confounded by the amount of cigarette smoking. Int J Cardiol. January 10, 2012 [Epub ahead of print
8. London GM, et al. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731-1740 (Pubitemid 37098542)
9. Okuno S, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007;49(3):417-425
10. Jean G, et al. Peripheral vascular calcification in longhaemodialysis patients: Associated factors and survival consequences. Nephrol Dial Transplant. 2009;24(3):948-955
11. Inaba M, et al. Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int. 2006;17(10):1506-1513 (Pubitemid 44387485)
12. Ix JH, et al. Fibroblast growth factor-23 and early decrements in kidney function: The Heart and Soul Study. Nephrol Dial Transplant. 2010;25(3):993-997
13. Isakova T, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. J Am Med Assoc. 2011;305(23):2432-2439
14. Jean G, et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant. 2009;24(9): 2792-2796
15. Gutierrez OM, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359(6):584-592
16. Holden RM, et al. FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients. Hemodial Int. 2012;16 (1):53-58
17. Canziani ME, et al. Fibroblast growth factor 23 in chronic kidney disease: Bridging the gap between bone mineral metabolism and left ventricular hypertrophy. Blood Purif. 2011;31 (1-3):26-32
18. Faul C, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393-4408
19. Seiler S, et al. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J. 2011;32 (21):2688-2696
20. Nasrallah MM, et al. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant. 2010;25 (8):2679-2685
21. Isakova T, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79(12):1370-1378
22. Gutierrez OM,Wolf M, Taylor EN. Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol. 2011;6(12):2871-2878
23. Koiwa F, et al. Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients. Ther Apher Dial. 2005;9(4):336-339 (Pubitemid 41800805)
24. Gonzalez-Parra E, et al. Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients. Nephrol Dial Transplant. 2011;26(8):2567-2571
25. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006;91 (8):3144-3149 (Pubitemid 44271770)
26. Burnett SM, et al. Regulation of C-Terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21(8):1187-1196
27. Shimada T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA. 2001;98(11):6500-6505 (Pubitemid 32488266)
28. Gutierrez O, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005;16 (7):2205-2215 (Pubitemid 41716454)
29. Torres PU, et al. Klotho: An antiaging protein involved in mineral and vitamin D metabolism. Kidney Int. 2007;71 (8):730-737
30. Urakawa I, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444 (7120):770-774 (Pubitemid 44949607)